Sumitomo Chemical: new API manufacturing plant in Japan
Sumitomo Chemical has announced plans to build a new manufacturing plant for active pharmaceutical ingredients (APIs) and intermediates for small molecule drugs at its Oita Works site in Oita City, Oita Prefecture, Japan. This project reportedly is intended to enhance the company’s capacity to supply a variety of high-quality APIs and intermediates to meet growing demand for small-molecule drugs; the plant is slated to open in September 2024.
The new plant will manufacture a wide variety of APIs and intermediates requiring complex chemical reactions and offer the ability to scale from development to commercialization. It will be compliant with US, EU, and Japanese GMP3, regulatory standards for pharmaceutical manufacturing and quality management.